Amgen fails again.
The company's PREPARE trial failed to show any positive response in breast cancer patients treated with chemotherapy and its drug Aranesp before surgery.
Why am I not surprised?
The only thing this dog has been successful at doing is giving investors fleas.
Much more here.
No comments:
Post a Comment